top of page
Primary care .png

AEYE For Endocrinologists

Point of Care Screening

Screening for Diabetic Retinopathy Using AI Instead of Referring to a Specialist

AEYE Health’s FDA-cleared AI delivers fast, autonomous diabetic retinopathy screening directly in your endocrinology clinic. In just 1 minute, staff can complete screening during routine visits, streamlining the care pathway and reducing the risk of diabetes-related vision loss. In-office screening also generates reimbursement through CPT 92229 while helping improve diabetic eye exam adherence and HEDIS performance.

Advantages of AEYE-DS

Group 6356511.png

Seamless EMR Integration

Full integration with Epic and other EMR systems, enabling automated coding, billing, reporting and referral 

Vector Art of hand is positioned beneath the eye vector icon symbolizing care and support and representing practical

1-minute Screening

Requires only one image per eye; no dilation; producing instant diagnosis

Group 6356496.png

Practical to Operate

Can be operated with a portable handheld camera and a robotic tabletop camera

Benefits of Point of Care Screening

vector art of reimbursable report

Reimbursable​

 Dedicated CPT code 92229 for AI diabetic retinopathy screening

Group 6356509_edited.png

Closes Care Gaps​

Closes the care diabetic eye gap, improving HEDIS scores and Star ratings

Vector Art of AEYE Health Care - An image has two vector hands catching the heart representing closes care gaps

Improve Patient Outcomes

Point-of-care screening ensures adherence to screening protocols and protects patients’ sight

See It in Action

  AEYE-DS with Optomed

AEYE with Topcon

Set up a call to find the best solution for you

Billing and Reimbursement for Diabetic Retinopathy Screening in Primary Care

Visual depiction of the billing and reimbursement process, featuring a central icon representing the exam with three outcomes: reimbursement for primary care providers using CPT 92229, improvement in HEDIS scores, and enhancement of Star-ratings. Additionally, the illustration highlights the addressing of point-of-care screening payment programs.

Reimbursable by Endocrinologists

CPT code 92229 was created for endocrinology providers and covers retinal imaging for the detection or monitoring of diabetic retinopathy, including point-of-care automated analysis and reporting.

Improves HEDIS scores and Star-ratings

Diabetic eye exams performed by endocrinology providers can be reported using CPT Category II codes and counted toward various HEDIS measures, helping practices enhance quality metrics and patient outcomes.

Addresses point-of-care screening payment programs

Screening for diabetic retinopathy addresses MIPS measure 117 and may qualify PCPs for additional payer incentives

Autonomous Diagnostic Screening Specialist | AEYE Health

Explore How You Can Implement Sight-Saving Diagnostic Screening

Thanks for submitting!

Schedule a Demo
bottom of page